The mechanism of action of antiviral drugs is mainly to inhibit the entry of viral particles into host cells and to inhibit the early stages of viral replication. There is also an inhibitor of DNA polymerase, which is mainly due to its ability to inhibit viral coding. At present, new antiviral drugs are actively seeking host factors, both in the initial stage of viral infection and in the later stages of nuclear transport of viral RNP complexes, to produce new drugs with new modes of action without drug resistance.

Market Analysis and Insights: Global Novel Antiviral Drugs Market

The global Novel Antiviral Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Novel Antiviral Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Novel Antiviral Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Novel Antiviral Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Novel Antiviral Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Novel Antiviral Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Novel Antiviral Drugs revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Novel Antiviral Drugs Market Report

Report Metric	Details
Report Name	Novel Antiviral Drugs Market
CAGR	5%
Segment by Type	Reverse Transcriptase Inhibitors Protease Inhibitors Fusion Inhibitors Immune System Modulators Other
Segment by Application	Hepatitis Therapeutics HIV/AIDS Therapeutics Herpes Therapeutics Influenza Therapeutics Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche Holding AG, GlaxoSmithKline, Bristol-Myers Squibb, AbbVie, Johnson & Johnson, Merck & Co, Novartis, Dr Reddy’s, Gilead Sciences, Aurobindo Pharma, Cipla
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Novel Antiviral Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Novel Antiviral Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Novel Antiviral Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Novel Antiviral Drugs Market report?

Ans: The main players in the Novel Antiviral Drugs Market are Roche Holding AG, GlaxoSmithKline, Bristol-Myers Squibb, AbbVie, Johnson & Johnson, Merck & Co, Novartis, Dr Reddy’s, Gilead Sciences, Aurobindo Pharma, Cipla

What are the Application segmentation covered in the Novel Antiviral Drugs Market report?

Ans: The Applications covered in the Novel Antiviral Drugs Market report are Hepatitis Therapeutics, HIV/AIDS Therapeutics, Herpes Therapeutics, Influenza Therapeutics, Other

What are the Type segmentation covered in the Novel Antiviral Drugs Market report?

Ans: The Types covered in the Novel Antiviral Drugs Market report are Reverse Transcriptase Inhibitors, Protease Inhibitors, Fusion Inhibitors, Immune System Modulators, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Novel Antiviral Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Reverse Transcriptase Inhibitors

1.2.3 Protease Inhibitors

1.2.4 Fusion Inhibitors

1.2.5 Immune System Modulators

1.2.6 Other

1.3 Market by Application

1.3.1 Global Novel Antiviral Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hepatitis Therapeutics

1.3.3 HIV/AIDS Therapeutics

1.3.4 Herpes Therapeutics

1.3.5 Influenza Therapeutics

1.3.6 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Novel Antiviral Drugs Market Perspective (2019-2030)

2.2 Global Novel Antiviral Drugs Growth Trends by Region

2.2.1 Novel Antiviral Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Novel Antiviral Drugs Historic Market Size by Region (2019-2024)

2.2.3 Novel Antiviral Drugs Forecasted Market Size by Region (2025-2030)

2.3 Novel Antiviral Drugs Market Dynamics

2.3.1 Novel Antiviral Drugs Industry Trends

2.3.2 Novel Antiviral Drugs Market Drivers

2.3.3 Novel Antiviral Drugs Market Challenges

2.3.4 Novel Antiviral Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Novel Antiviral Drugs by Players

3.1.1 Global Novel Antiviral Drugs Revenue by Players (2019-2024)

3.1.2 Global Novel Antiviral Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Novel Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Novel Antiviral Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Novel Antiviral Drugs Market Concentration Ratio

3.4.1 Global Novel Antiviral Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Novel Antiviral Drugs Revenue in 2023

3.5 Global Key Players of Novel Antiviral Drugs Head office and Area Served

3.6 Global Key Players of Novel Antiviral Drugs, Product and Application

3.7 Global Key Players of Novel Antiviral Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Novel Antiviral Drugs Breakdown Data by Type

4.1 Global Novel Antiviral Drugs Historic Market Size by Type (2019-2024)

4.2 Global Novel Antiviral Drugs Forecasted Market Size by Type (2025-2030)

5 Novel Antiviral Drugs Breakdown Data by Application

5.1 Global Novel Antiviral Drugs Historic Market Size by Application (2019-2024)

5.2 Global Novel Antiviral Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Novel Antiviral Drugs Market Size (2019-2030)

6.2 North America Novel Antiviral Drugs Market Size by Type

6.2.1 North America Novel Antiviral Drugs Market Size by Type (2019-2024)

6.2.2 North America Novel Antiviral Drugs Market Size by Type (2025-2030)

6.2.3 North America Novel Antiviral Drugs Market Share by Type (2019-2030)

6.3 North America Novel Antiviral Drugs Market Size by Application

6.3.1 North America Novel Antiviral Drugs Market Size by Application (2019-2024)

6.3.2 North America Novel Antiviral Drugs Market Size by Application (2025-2030)

6.3.3 North America Novel Antiviral Drugs Market Share by Application (2019-2030)

6.4 North America Novel Antiviral Drugs Market Size by Country

6.4.1 North America Novel Antiviral Drugs Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Novel Antiviral Drugs Market Size by Country (2019-2024)

6.4.3 North America Novel Antiviral Drugs Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Novel Antiviral Drugs Market Size (2019-2030)

7.2 Europe Novel Antiviral Drugs Market Size by Type

7.2.1 Europe Novel Antiviral Drugs Market Size by Type (2019-2024)

7.2.2 Europe Novel Antiviral Drugs Market Size by Type (2025-2030)

7.2.3 Europe Novel Antiviral Drugs Market Share by Type (2019-2030)

7.3 Europe Novel Antiviral Drugs Market Size by Application

7.3.1 Europe Novel Antiviral Drugs Market Size by Application (2019-2024)

7.3.2 Europe Novel Antiviral Drugs Market Size by Application (2025-2030)

7.3.3 Europe Novel Antiviral Drugs Market Share by Application (2019-2030)

7.4 Europe Novel Antiviral Drugs Market Size by Country

7.4.1 Europe Novel Antiviral Drugs Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Novel Antiviral Drugs Market Size by Country (2019-2024)

7.4.3 Europe Novel Antiviral Drugs Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Novel Antiviral Drugs Market Size (2019-2030)

8.2 China Novel Antiviral Drugs Market Size by Type

8.2.1 China Novel Antiviral Drugs Market Size by Type (2019-2024)

8.2.2 China Novel Antiviral Drugs Market Size by Type (2025-2030)

8.2.3 China Novel Antiviral Drugs Market Share by Type (2019-2030)

8.3 China Novel Antiviral Drugs Market Size by Application

8.3.1 China Novel Antiviral Drugs Market Size by Application (2019-2024)

8.3.2 China Novel Antiviral Drugs Market Size by Application (2025-2030)

8.3.3 China Novel Antiviral Drugs Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Novel Antiviral Drugs Market Size (2019-2030)

9.2 Asia Novel Antiviral Drugs Market Size by Type

9.2.1 Asia Novel Antiviral Drugs Market Size by Type (2019-2024)

9.2.2 Asia Novel Antiviral Drugs Market Size by Type (2025-2030)

9.2.3 Asia Novel Antiviral Drugs Market Share by Type (2019-2030)

9.3 Asia Novel Antiviral Drugs Market Size by Application

9.3.1 Asia Novel Antiviral Drugs Market Size by Application (2019-2024)

9.3.2 Asia Novel Antiviral Drugs Market Size by Application (2025-2030)

9.3.3 Asia Novel Antiviral Drugs Market Share by Application (2019-2030)

9.4 Asia Novel Antiviral Drugs Market Size by Region

9.4.1 Asia Novel Antiviral Drugs Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Novel Antiviral Drugs Market Size by Region (2019-2024)

9.4.3 Asia Novel Antiviral Drugs Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Type

10.2.1 Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Novel Antiviral Drugs Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Application

10.3.1 Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Novel Antiviral Drugs Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Country

10.4.1 Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Roche Holding AG

11.1.1 Roche Holding AG Company Details

11.1.2 Roche Holding AG Business Overview

11.1.3 Roche Holding AG Novel Antiviral Drugs Introduction

11.1.4 Roche Holding AG Revenue in Novel Antiviral Drugs Business (2019-2024)

11.1.5 Roche Holding AG Recent Developments

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Company Details

11.2.2 GlaxoSmithKline Business Overview

11.2.3 GlaxoSmithKline Novel Antiviral Drugs Introduction

11.2.4 GlaxoSmithKline Revenue in Novel Antiviral Drugs Business (2019-2024)

11.2.5 GlaxoSmithKline Recent Developments

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Novel Antiviral Drugs Introduction

11.3.4 Bristol-Myers Squibb Revenue in Novel Antiviral Drugs Business (2019-2024)

11.3.5 Bristol-Myers Squibb Recent Developments

11.4 AbbVie

11.4.1 AbbVie Company Details

11.4.2 AbbVie Business Overview

11.4.3 AbbVie Novel Antiviral Drugs Introduction

11.4.4 AbbVie Revenue in Novel Antiviral Drugs Business (2019-2024)

11.4.5 AbbVie Recent Developments

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Novel Antiviral Drugs Introduction

11.5.4 Johnson & Johnson Revenue in Novel Antiviral Drugs Business (2019-2024)

11.5.5 Johnson & Johnson Recent Developments

11.6 Merck & Co

11.6.1 Merck & Co Company Details

11.6.2 Merck & Co Business Overview

11.6.3 Merck & Co Novel Antiviral Drugs Introduction

11.6.4 Merck & Co Revenue in Novel Antiviral Drugs Business (2019-2024)

11.6.5 Merck & Co Recent Developments

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Novel Antiviral Drugs Introduction

11.7.4 Novartis Revenue in Novel Antiviral Drugs Business (2019-2024)

11.7.5 Novartis Recent Developments

11.8 Dr Reddy’s

11.8.1 Dr Reddy’s Company Details

11.8.2 Dr Reddy’s Business Overview

11.8.3 Dr Reddy’s Novel Antiviral Drugs Introduction

11.8.4 Dr Reddy’s Revenue in Novel Antiviral Drugs Business (2019-2024)

11.8.5 Dr Reddy’s Recent Developments

11.9 Gilead Sciences

11.9.1 Gilead Sciences Company Details

11.9.2 Gilead Sciences Business Overview

11.9.3 Gilead Sciences Novel Antiviral Drugs Introduction

11.9.4 Gilead Sciences Revenue in Novel Antiviral Drugs Business (2019-2024)

11.9.5 Gilead Sciences Recent Developments

11.10 Aurobindo Pharma

11.10.1 Aurobindo Pharma Company Details

11.10.2 Aurobindo Pharma Business Overview

11.10.3 Aurobindo Pharma Novel Antiviral Drugs Introduction

11.10.4 Aurobindo Pharma Revenue in Novel Antiviral Drugs Business (2019-2024)

11.10.5 Aurobindo Pharma Recent Developments

11.11 Cipla

11.11.1 Cipla Company Details

11.11.2 Cipla Business Overview

11.11.3 Cipla Novel Antiviral Drugs Introduction

11.11.4 Cipla Revenue in Novel Antiviral Drugs Business (2019-2024)

11.11.5 Cipla Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Novel Antiviral Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Reverse Transcriptase Inhibitors

Table 3. Key Players of Protease Inhibitors

Table 4. Key Players of Fusion Inhibitors

Table 5. Key Players of Immune System Modulators

Table 6. Key Players of Other

Table 7. Global Novel Antiviral Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 8. Global Novel Antiviral Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Novel Antiviral Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Novel Antiviral Drugs Market Share by Region (2019-2024)

Table 11. Global Novel Antiviral Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Novel Antiviral Drugs Market Share by Region (2025-2030)

Table 13. Novel Antiviral Drugs Market Trends

Table 14. Novel Antiviral Drugs Market Drivers

Table 15. Novel Antiviral Drugs Market Challenges

Table 16. Novel Antiviral Drugs Market Restraints

Table 17. Global Novel Antiviral Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Novel Antiviral Drugs Revenue Share by Players (2019-2024)

Table 19. Global Top Novel Antiviral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Antiviral Drugs as of 2023)

Table 20. Global Novel Antiviral Drugs Industry Ranking 2022 VS 2023 VS 2024

Table 21. Global 5 Largest Players Market Share by Novel Antiviral Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Novel Antiviral Drugs, Headquarters and Area Served

Table 23. Global Key Players of Novel Antiviral Drugs, Product and Application

Table 24. Global Key Players of Novel Antiviral Drugs, Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Novel Antiviral Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Novel Antiviral Drugs Revenue Market Share by Type (2019-2024)

Table 28. Global Novel Antiviral Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Novel Antiviral Drugs Revenue Market Share by Type (2025-2030)

Table 30. Global Novel Antiviral Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Novel Antiviral Drugs Revenue Share by Application (2019-2024)

Table 32. Global Novel Antiviral Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Novel Antiviral Drugs Revenue Share by Application (2025-2030)

Table 34. North America Novel Antiviral Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Novel Antiviral Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Novel Antiviral Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Novel Antiviral Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Novel Antiviral Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Novel Antiviral Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Novel Antiviral Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Novel Antiviral Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Novel Antiviral Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Novel Antiviral Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Novel Antiviral Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Novel Antiviral Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Novel Antiviral Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Novel Antiviral Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Novel Antiviral Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Novel Antiviral Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Novel Antiviral Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Novel Antiviral Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Novel Antiviral Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Novel Antiviral Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Novel Antiviral Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Novel Antiviral Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Novel Antiviral Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Novel Antiviral Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Novel Antiviral Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Novel Antiviral Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 66. Roche Holding AG Company Details

Table 67. Roche Holding AG Business Overview

Table 68. Roche Holding AG Novel Antiviral Drugs Product

Table 69. Roche Holding AG Revenue in Novel Antiviral Drugs Business (2019-2024) & (US$ Million)

Table 70. Roche Holding AG Recent Developments

Table 71. GlaxoSmithKline Company Details

Table 72. GlaxoSmithKline Business Overview

Table 73. GlaxoSmithKline Novel Antiviral Drugs Product

Table 74. GlaxoSmithKline Revenue in Novel Antiviral Drugs Business (2019-2024) & (US$ Million)

Table 75. GlaxoSmithKline Recent Developments

Table 76. Bristol-Myers Squibb Company Details

Table 77. Bristol-Myers Squibb Business Overview

Table 78. Bristol-Myers Squibb Novel Antiviral Drugs Product

Table 79. Bristol-Myers Squibb Revenue in Novel Antiviral Drugs Business (2019-2024) & (US$ Million)

Table 80. Bristol-Myers Squibb Recent Developments

Table 81. AbbVie Company Details

Table 82. AbbVie Business Overview

Table 83. AbbVie Novel Antiviral Drugs Product

Table 84. AbbVie Revenue in Novel Antiviral Drugs Business (2019-2024) & (US$ Million)

Table 85. AbbVie Recent Developments

Table 86. Johnson & Johnson Company Details

Table 87. Johnson & Johnson Business Overview

Table 88. Johnson & Johnson Novel Antiviral Drugs Product

Table 89. Johnson & Johnson Revenue in Novel Antiviral Drugs Business (2019-2024) & (US$ Million)

Table 90. Johnson & Johnson Recent Developments

Table 91. Merck & Co Company Details

Table 92. Merck & Co Business Overview

Table 93. Merck & Co Novel Antiviral Drugs Product

Table 94. Merck & Co Revenue in Novel Antiviral Drugs Business (2019-2024) & (US$ Million)

Table 95. Merck & Co Recent Developments

Table 96. Novartis Company Details

Table 97. Novartis Business Overview

Table 98. Novartis Novel Antiviral Drugs Product

Table 99. Novartis Revenue in Novel Antiviral Drugs Business (2019-2024) & (US$ Million)

Table 100. Novartis Recent Developments

Table 101. Dr Reddy’s Company Details

Table 102. Dr Reddy’s Business Overview

Table 103. Dr Reddy’s Novel Antiviral Drugs Product

Table 104. Dr Reddy’s Revenue in Novel Antiviral Drugs Business (2019-2024) & (US$ Million)

Table 105. Dr Reddy’s Recent Developments

Table 106. Gilead Sciences Company Details

Table 107. Gilead Sciences Business Overview

Table 108. Gilead Sciences Novel Antiviral Drugs Product

Table 109. Gilead Sciences Revenue in Novel Antiviral Drugs Business (2019-2024) & (US$ Million)

Table 110. Gilead Sciences Recent Developments

Table 111. Aurobindo Pharma Company Details

Table 112. Aurobindo Pharma Business Overview

Table 113. Aurobindo Pharma Novel Antiviral Drugs Product

Table 114. Aurobindo Pharma Revenue in Novel Antiviral Drugs Business (2019-2024) & (US$ Million)

Table 115. Aurobindo Pharma Recent Developments

Table 116. Cipla Company Details

Table 117. Cipla Business Overview

Table 118. Cipla Novel Antiviral Drugs Product

Table 119. Cipla Revenue in Novel Antiviral Drugs Business (2019-2024) & (US$ Million)

Table 120. Cipla Recent Developments

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Novel Antiviral Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Novel Antiviral Drugs Market Share by Type: 2023 VS 2030

Figure 3. Reverse Transcriptase Inhibitors Features

Figure 4. Protease Inhibitors Features

Figure 5. Fusion Inhibitors Features

Figure 6. Immune System Modulators Features

Figure 7. Other Features

Figure 8. Global Novel Antiviral Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Novel Antiviral Drugs Market Share by Application: 2023 VS 2030

Figure 10. Hepatitis Therapeutics Case Studies

Figure 11. HIV/AIDS Therapeutics Case Studies

Figure 12. Herpes Therapeutics Case Studies

Figure 13. Influenza Therapeutics Case Studies

Figure 14. Other Case Studies

Figure 15. Novel Antiviral Drugs Report Years Considered

Figure 16. Global Novel Antiviral Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Novel Antiviral Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Novel Antiviral Drugs Market Share by Region: 2023 VS 2030

Figure 19. Global Novel Antiviral Drugs Market Share by Players in 2023

Figure 20. Global Top Novel Antiviral Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Antiviral Drugs as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Novel Antiviral Drugs Revenue in 2023

Figure 22. North America Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Novel Antiviral Drugs Market Share by Type (2019-2030)

Figure 24. North America Novel Antiviral Drugs Market Share by Application (2019-2030)

Figure 25. North America Novel Antiviral Drugs Market Share by Country (2019-2030)

Figure 26. United States Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Novel Antiviral Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 29. Europe Novel Antiviral Drugs Market Share by Type (2019-2030)

Figure 30. Europe Novel Antiviral Drugs Market Share by Application (2019-2030)

Figure 31. Europe Novel Antiviral Drugs Market Share by Country (2019-2030)

Figure 32. Germany Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. France Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. U.K. Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Italy Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Russia Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Nordic Countries Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. China Novel Antiviral Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 39. China Novel Antiviral Drugs Market Share by Type (2019-2030)

Figure 40. China Novel Antiviral Drugs Market Share by Application (2019-2030)

Figure 41. Asia Novel Antiviral Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 42. Asia Novel Antiviral Drugs Market Share by Type (2019-2030)

Figure 43. Asia Novel Antiviral Drugs Market Share by Application (2019-2030)

Figure 44. Asia Novel Antiviral Drugs Market Share by Region (2019-2030)

Figure 45. Japan Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. South Korea Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. China Taiwan Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. India Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Australia Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Novel Antiviral Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America Novel Antiviral Drugs Market Share by Type (2019-2030)

Figure 53. Middle East, Africa, and Latin America Novel Antiviral Drugs Market Share by Application (2019-2030)

Figure 54. Middle East, Africa, and Latin America Novel Antiviral Drugs Market Share by Country (2019-2030)

Figure 55. Brazil Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Mexico Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Turkey Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Saudi Arabia Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Israel Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. GCC Countries Novel Antiviral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. Roche Holding AG Revenue Growth Rate in Novel Antiviral Drugs Business (2019-2024)

Figure 62. GlaxoSmithKline Revenue Growth Rate in Novel Antiviral Drugs Business (2019-2024)

Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Novel Antiviral Drugs Business (2019-2024)

Figure 64. AbbVie Revenue Growth Rate in Novel Antiviral Drugs Business (2019-2024)

Figure 65. Johnson & Johnson Revenue Growth Rate in Novel Antiviral Drugs Business (2019-2024)

Figure 66. Merck & Co Revenue Growth Rate in Novel Antiviral Drugs Business (2019-2024)

Figure 67. Novartis Revenue Growth Rate in Novel Antiviral Drugs Business (2019-2024)

Figure 68. Dr Reddy’s Revenue Growth Rate in Novel Antiviral Drugs Business (2019-2024)

Figure 69. Gilead Sciences Revenue Growth Rate in Novel Antiviral Drugs Business (2019-2024)

Figure 70. Aurobindo Pharma Revenue Growth Rate in Novel Antiviral Drugs Business (2019-2024)

Figure 71. Cipla Revenue Growth Rate in Novel Antiviral Drugs Business (2019-2024)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Antiviral Drugs Market

Influenza Diagnostics Market

Direct acting Antiviral Drugs Market

Influenza Antiviral Drugs Market

Antiviral Therapy Market

HIV Therapeutics Market

Protease Inhibitors Market

Hepatitis B Therapeutics Market

Anti Viral Coatings Market

Sterile and Antiviral Packaging Market

Specific Antiviral Drugs for COVID 19 Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions